《中国急性胰腺炎诊治指南（2021）》解读

2021-07-01 中国实用外科杂志. 2021,41(07)

近年来,急性胰腺炎（AP）在诊治理念、方式和策略等方面发生了重要变革,对其诊断和治疗的诸多方面产生了深远影响。基于此,2020年底中华医学会外科学分会胰腺外科学组牵头,在《重症急性胰腺炎诊治指南（20

中文标题：

发布机构：

发布日期：

2021-07-01

简要介绍：

近年来,急性胰腺炎（AP）在诊治理念、方式和策略等方面发生了重要变革,对其诊断和治疗的诸多方面产生了深远影响。基于此,2020年底中华医学会外科学分会胰腺外科学组牵头,在《重症急性胰腺炎诊治指南（2007）》和《急性胰腺炎诊治指南（2014）》的基础上,更新并制定了《急性胰腺炎诊治指南（2021）》。新版指南采用以问题为导向的表述方式,重点阐释了AP的诊断与分类标准,AP早期的液体治疗、镇痛与营养支持治疗及后期感染性并发症的处理,同时提出了AP的随访策略。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=033261c002136932, title=《中国急性胰腺炎诊治指南（2021）》解读, enTitle=, guiderFrom=中国实用外科杂志. 2021,41(07), authorId=0, author=, summary=近年来,急性胰腺炎（AP）在诊治理念、方式和策略等方面发生了重要变革,对其诊断和治疗的诸多方面产生了深远影响。基于此,2020年底中华医学会外科学分会胰腺外科学组牵头,在《重症急性胰腺炎诊治指南（20, cover=https://img.medsci.cn/2021725/1627227152850_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Jul 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">近年来,急性胰腺炎（AP）在诊治理念、方式和策略等方面发生了重要变革,对其诊断和治疗的诸多方面产生了深远影响。基于此,2020年底中华医学会外科学分会胰腺外科学组牵头,在《重症急性胰腺炎诊治指南（2007）》和《急性胰腺炎诊治指南（2014）》的基础上,更新并制定了《急性胰腺炎诊治指南（2021）》。新版指南采用以问题为导向的表述方式,重点阐释了AP的诊断与分类标准,AP早期的液体治疗、镇痛与营养支持治疗及后期感染性并发症的处理,同时提出了AP的随访策略。 </span></p>, tagList=[TagDto(tagId=322, tagName=急性胰腺炎)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=322, guiderKeyword=急性胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=13160, appHits=841, showAppHits=0, pcHits=2615, showPcHits=12317, likes=4, shares=77, comments=20, approvalStatus=1, publishedTime=Sun Jul 25 23:40:28 CST 2021, publishedTimeString=2021-07-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 25 23:33:10 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:49:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_中国急性胰腺炎诊治指南_2021_解读_曹锋.pdf)])

_中国急性胰腺炎诊治指南_2021_解读_曹锋.pdf

下载请点击：

评论区 (17)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2089115, encodeId=80be20891156e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a668335627, createdName=ms3000000504315147, createdTime=Mon Sep 19 22:04:54 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220773, encodeId=4e841220e73e8, content=个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=590c6588328, createdName=ms8000002069097849, createdTime=Wed May 18 21:50:45 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202020, encodeId=4d701202020f8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Sat Mar 12 16:49:41 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200598, encodeId=7e5c120059873, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:11:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198846, encodeId=ecd811988462e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19a6466567, createdName=ms4000001298945835, createdTime=Wed Mar 02 20:44:44 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
2022-09-19 ms3000000504315147

好

49 0
[GetPortalCommentsPageByObjectIdResponse(id=2089115, encodeId=80be20891156e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a668335627, createdName=ms3000000504315147, createdTime=Mon Sep 19 22:04:54 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220773, encodeId=4e841220e73e8, content=个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=590c6588328, createdName=ms8000002069097849, createdTime=Wed May 18 21:50:45 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202020, encodeId=4d701202020f8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Sat Mar 12 16:49:41 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200598, encodeId=7e5c120059873, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:11:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198846, encodeId=ecd811988462e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19a6466567, createdName=ms4000001298945835, createdTime=Wed Mar 02 20:44:44 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
2022-05-18 ms8000002069097849

个

56 0
[GetPortalCommentsPageByObjectIdResponse(id=2089115, encodeId=80be20891156e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a668335627, createdName=ms3000000504315147, createdTime=Mon Sep 19 22:04:54 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220773, encodeId=4e841220e73e8, content=个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=590c6588328, createdName=ms8000002069097849, createdTime=Wed May 18 21:50:45 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202020, encodeId=4d701202020f8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Sat Mar 12 16:49:41 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200598, encodeId=7e5c120059873, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:11:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198846, encodeId=ecd811988462e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19a6466567, createdName=ms4000001298945835, createdTime=Wed Mar 02 20:44:44 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
2022-03-12 ms2000001285500485

很好

44 0
[GetPortalCommentsPageByObjectIdResponse(id=2089115, encodeId=80be20891156e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a668335627, createdName=ms3000000504315147, createdTime=Mon Sep 19 22:04:54 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220773, encodeId=4e841220e73e8, content=个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=590c6588328, createdName=ms8000002069097849, createdTime=Wed May 18 21:50:45 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202020, encodeId=4d701202020f8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Sat Mar 12 16:49:41 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200598, encodeId=7e5c120059873, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:11:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198846, encodeId=ecd811988462e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19a6466567, createdName=ms4000001298945835, createdTime=Wed Mar 02 20:44:44 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
2022-03-08 gghhzb

很实用

46 0
[GetPortalCommentsPageByObjectIdResponse(id=2089115, encodeId=80be20891156e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a668335627, createdName=ms3000000504315147, createdTime=Mon Sep 19 22:04:54 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220773, encodeId=4e841220e73e8, content=个, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=590c6588328, createdName=ms8000002069097849, createdTime=Wed May 18 21:50:45 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202020, encodeId=4d701202020f8, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75ac5643914, createdName=ms2000001285500485, createdTime=Sat Mar 12 16:49:41 CST 2022, time=2022-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200598, encodeId=7e5c120059873, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:11:29 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198846, encodeId=ecd811988462e, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a19a6466567, createdName=ms4000001298945835, createdTime=Wed Mar 02 20:44:44 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
2022-03-02 ms4000001298945835

很好

47 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化指南

《中国急性胰腺炎诊治指南（2021）》解读

相关指南

拓展阅读

科室

工具

服务